Attenuated IL-2 muteins leverage the TCR signal to enhance regulatory T cell homeostasis and response in vivo

Interleukin-2 (IL-2), along with T-cell receptor (TCR) signaling, are required to control regulatory T cell (Treg) homeostasis and function in vivo. Due to the heightened sensitivity to IL-2, Tregs retain the ability to respond to low-dose or attenuated forms of IL-2, as currently being developed fo...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Shining Ma, Michelle So, Aazam Ghelani, Rohith Srivas, Anupama Sahoo, Robyn Hall, Wenjun Liu, Hao Wu, Sherman Yu, Shiping Lu, Elly Song, Taryn Cariaga, Marcus Soto, Hong Zhou, Chi-Ming Li, Ashutosh Chaudhry, Xin Luo, Sue J. Sohn
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	Frontiers Media S.A. 2023-09-01
Sarja:	Frontiers in Immunology
Aiheet:	regulatory T cell (Treg) interleukin-2 (IL-2) IL-2 therapy cytokine T cell receptor (TCR) in vivo
Linkit:	https://www.frontiersin.org/articles/10.3389/fimmu.2023.1257652/full
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!